Elite Pharmaceuticals Inc (ELTP)
0.5875
-0.02
(-3.07%)
USD |
OTCM |
Nov 26, 16:00
Elite Pharmaceuticals Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | -0.0422M |
June 30, 2020 | |
March 31, 2020 | -0.631M |
December 31, 2019 | -0.0831M |
September 30, 2019 | -0.3836M |
June 30, 2019 | -0.3403M |
March 31, 2019 | -0.3937M |
December 31, 2018 | -0.2735M |
September 30, 2018 | -1.228M |
June 30, 2018 | -0.1682M |
March 31, 2018 | -0.7918M |
December 31, 2017 | -0.2524M |
September 30, 2017 | -0.5319M |
June 30, 2017 | -0.4238M |
March 31, 2017 | -1.823M |
December 31, 2016 | -1.238M |
September 30, 2016 | -2.061M |
June 30, 2016 | -2.470M |
March 31, 2016 | -2.910M |
December 31, 2015 | -0.5091M |
September 30, 2015 | -0.7396M |
June 30, 2015 | -2.041M |
March 31, 2015 | -3.558M |
Date | Value |
---|---|
December 31, 2014 | -3.451M |
September 30, 2014 | -5.331M |
June 30, 2014 | -0.8966M |
March 31, 2014 | -6.49M |
December 31, 2013 | -1.61M |
September 30, 2013 | -1.50M |
June 30, 2013 | -0.40M |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 | |
June 30, 2009 | |
March 31, 2009 | |
December 31, 2008 | 1.777M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-0.631M
Minimum
Mar 2020
--
Maximum
Dec 2020
-0.1513M
Average
-0.0422M
Median
Sep 2020
Stock Buybacks (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | -- |
BioCardia Inc | -7.198M |
Zevra Therapeutics Inc | -64.67M |
Verrica Pharmaceuticals Inc | 0.00 |
Terns Pharmaceuticals Inc | -162.31M |